Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ World https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The Indian Serum Institute plans to start producing vaccines outside India

The Indian Serum Institute plans to start producing vaccines outside India



Bloomberg

How the vaccine in India disintegrated and left the country in chaos

(Bloomberg) – When India launched its Covid-19 vaccination campaign in mid-January, the chances of success looked high: it could produce more shots than any country in the world and had decades of experience in inoculating pregnant women and babies in rural areas. “Our preparations were such that the vaccine quickly reached all parts of the country,”

; Prime Minister Narendra Modi said on January 22nd. “In the world’s greatest need today, we are completely independent. Not only that, India also helps many countries with vaccines. “A little over three months later, this initial promise has evaporated and the government’s plans are in disarray. India has completely vaccinated less than 2% of its population with 1.3 billion people, inoculation centers across the country say they lack doses and exports have stopped. Instead of building defenses, the South Asian country is setting daily records for new infections as a second wave takes over hospitals and crematoria. Modi responded by suddenly changing his vaccine and supply strategy. Initially, the federal government negotiated prices with manufacturers, distributed them in the states, and limited them to priority groups such as the elderly and health care workers. From May 1, everyone over the age of 18 is entitled to the vaccine, while state governments and private hospitals can buy doses directly from manufacturers for people between the ages of 18 and 45 – causing a desperate fast free for all to secure shots from the already clogged market. His government says the new rules make “the pricing, supply, eligibility and administration of vaccines open and flexible”. Health experts and officials in opposition-controlled countries say the plan transfers money to regional governments instead of addressing the pandemic directly. The expansion of photo distribution is also in question as India depletes its reserves, such as developers such as Serum Institute of India Ltd. they say the US is stockpiling ingredients and new supplies could remain for months. “No discussion” There was no discussion with state governments before asking states to procure vaccines themselves, “said TS Singh Deo, Chhattisgarh’s health minister. “As a country, we will have to buy vaccines from the open market, severely hampering our finances.” Given India’s growing strategic importance, the wave of infections risks not only the emerging recovery in Asia’s third-largest economy, but also attempts to affect Covid -19 and recovered worldwide. The nation is now the main hotspot of the pandemic, although it is home to the world’s largest vaccine maker. “The vaccination program really needs to be the center of attention,” said Raina McIntyre, a professor of biosecurity at the University of New South Wales in Sydney. “Vaccination in humans will also reduce the selective pressure for new strains to emerge.” Although easy to determine now, Modi’s government has missed opportunities to focus on supporting vaccine production and expanding its outdated health system. Excessive dependence on application-based technology has made it difficult for poor and rural citizens to register, and Modi’s plan does not use the million-strong army of trained health workers in India – accredited social health activists or ASHA – to reach its vast rural hinterland. a strategy that made polio vaccination so successful. Warning signs Instead, government officials focused on showing India’s ability to help the world. The Davos summit that India will help other countries with vaccines, the daily number of cases is 18,885 that day – compared to 379,257 on Thursday. At that time, the developers of serum and other vaccines were already warning of a shortage and pointing the finger at the United States. While plans to immunize countries around the world took a hit, life in India was almost normal. Millions of pilgrims immersed themselves in the holy river Ganges at the Hindu religious festival Kumbh Mela, while political parties held mass rallies in five state elections. Less than six weeks later, Health Minister Harsh Vardhan said, “We are at the end of the Covid-19 Pandemic game in India. “Even on March 30, when cases were on the rise again, Vardhan insisted the situation was ‘under control.'” There is no Kovid in Assam, “said Himanta Biswa Sarma, a member of Modi’s party, which serves as the country’s health minister. On April 16, the shortage of doses became so acute that Adar Poonavala, the CEO of Serum, wrote on Twitter in a direct message to President Joe Biden to Asked him to lift the US embargo on raw material exports Three days later, Modi abandoned his vaccination strategy and put the burden on the states – many of which are frustrated – India virtually cut off vaccines to other parts of the world. South India’s finance minister, Kerala Thomas Isaac, called Modi’s new vaccine plan a “smart political ploy” rather than a solution. “There was no coordination or consultation. how vaccination policy will work, ”said Balbir Singh Sidhu, health minister for the congressional opposition state in Punjab. “Everything is top-down.” A spokesman for the Indian Ministry of Health did not respond to calls and emails seeking comment. The big question now is how India can increase supplies to provide vaccines to another 600 million people. The shortage is already evident in the current program for taking pictures of those aged 45 and over, leading to a steady decline in vaccination across the country, even more than 10 million registered for doses when driving was discovered on Wednesday. two vaccine suppliers – the AstraZeneca Plc Shot Serum Institute; and Bharat Biotech International Ltd., who are doing internally developed inoculation, have been told they can expect deliveries to provincial governments from mid-May, although those who qualify can register for the April 28 photos. and Bharat Biotech said they could only increase capacity by July, with existing stocks split equally between the center and the states. New Delhi has released Russia’s Sputnik V for emergency use, and news reports say some imports may enter by May, but there are no specific figures on the quantity. The United States has promised to send materials to India to produce vaccines and share Astra vaccine stocks, but details are unclear. Then there are the costs. U.S. governments have been told they will have to pay between $ 5 and $ 8 for the shots, three times the federal government’s pay. Following a protest against the marches, Bharat Biotech announced on Thursday that it would reduce the amount it charges to 400 rupees ($ 5.4) from 600 rupees, a day after Serum CEO Adar Poonavala said his company would cut prices by 100 rupees. Rajesh Tope, Maharashtra’s health minister, home of the country’s financial capital Mumbai, said the state would spend 65 billion rupees to inoculate its residents for free, but could not expand the program for all adults because there were not enough doses. India was already one of the few countries to allow private sales of photos of Covid-19 when private hospitals began vaccinating at a fixed price of about $ 3 per dose. Now the price has risen to between $ 8 and $ 16 per dose, which means they apply them at even higher prices. “There must be a price for vaccine samples across India,” Arvind Subramanyan, a former chief economic adviser in the Modi administration, wrote on Twitter over the weekend. (“This price should be zero.” (Updates with reduced vaccine prices in paragraph 24.) For more articles like this, please visit us at bloomberg.com Subscribe now to stay ahead with the most trusted source of business news. © 2021 Bloomberg LP


Source link